NCT00872534 - Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Upper Gastrointestinal Mucosal Damage

Interventions

DRUG

acetylsalicylic acid

325mg once a day for 7 days

Trial Locations (6)

Jupiter Research, Jupiter

Miami Research Associates, South Miami

Oklahoma Foundation for Digestive Research, Oklahoma City

Altoona Arthritis and Osteoporosis Center, Altoona

Dallas VA Medical Center, Dallas

Houston Center For Clinical Research, Houston